State of Wyoming’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

State of Wyoming’s Portfolio PSTX Stock Details PSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-18,749	Closed	-$53.6K	–	1916
2024 Q3	$53.6K	Buy	+18,749	New	+$58K	0.01%	1412
2023 Q1	–	Sell	-7,146	Closed	-$37.9K	–	1815
2022 Q4	$37.9K	Buy	+7,146	New	+$32.7K	0.01%	1142

Other funds holding PSTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

State of Wyoming's PSTX Position: Q4 2024 in Review

State of Wyoming sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q4 2024, closing a stake of 18,749 shares — an estimated $53.6K sold.

State of Wyoming first reported a position in PSTX in Q4 2022 and held it in 2 quarters. The position peaked at $53.6K in Q3 2024. 115 funds tracked by Wall St. Rank hold PSTX as of Q4 2024.

State of Wyoming reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
State of Wyoming sold 18,749 Poseida Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $53.6K.
State of Wyoming first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
State of Wyoming's Poseida Therapeutics, Inc. Common Stock position peaked at $53.6K in Q3 2024.
115 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q4 2024.

Based on State of Wyoming's 13F filing for Q4 2024, filed 14 Feb 2025.